Skip to content
Travel Clinic

Dengue Fever Vaccine in London

A newer vaccine option for protection against dengue fever. Currently recommended primarily for those with confirmed previous dengue infection. Our pharmacist will assess your eligibility.

Starting from

£129

Protects against dengue — a mosquito-borne viral infection increasingly common in tropical and subtropical regions. 2-dose course for travellers with previous dengue infection.

Price

£129 per dose

Doses

2 (3 months apart)

Course cost

£230 total

Eligibility

Assessment required

Appointment

~20 minutes

Overview

Dengue fever is a mosquito-borne viral infection found in tropical and subtropical regions worldwide. It is transmitted by Aedes mosquitoes, which bite primarily during the day. The WHO estimates 100–400 million dengue infections occur each year, making it one of the most common mosquito-borne diseases globally. Dengue vaccine availability in the UK is evolving. At Holborn Clinic, we stock the latest approved options and will assess your eligibility based on your infection history and travel plans. Regardless of vaccination status, mosquito bite prevention (DEET-based repellent, long clothing, air-conditioned accommodation) remains the primary defence against dengue.

Holborn Travel Clinic is inside Boutalls Pharmacy at 60 Lamb's Conduit Street, London WC1N 3LW, minutes from Holborn and Russell Square stations.

Who Needs This Vaccine?

  • Travellers who have had a confirmed previous dengue infection and plan to revisit endemic areas — they are at highest risk of severe dengue on re-infection.
  • Frequent travellers to dengue-endemic areas in South-East Asia, South Asia, Central and South America, the Caribbean, and sub-Saharan Africa.
  • Long-stay travellers or expats in high-transmission areas.
  • Note: current dengue vaccines have specific eligibility criteria — our pharmacist will assess suitability based on your infection history and travel plans.

What to Expect

  • A consultation to assess your eligibility — current guidelines require evidence of previous dengue infection for some vaccines.
  • If eligible, the course is 2 doses given 3 months apart (Qdenga) as subcutaneous injections.
  • Mosquito bite prevention remains essential even after vaccination — no dengue vaccine provides 100% protection.

Side Effects

  • Common: injection site pain, headache, muscle pain, fatigue.
  • Uncommon: mild fever or joint pain for 1–2 days.
  • Serious side effects are rare. The vaccine is not suitable for everyone — screening is essential.
Destinations

Common Destinations Requiring This Vaccine

A selection of countries where this vaccine is commonly required — many more may apply. See our destination guides for the full list.

ThailandIndiaVietnamBrazilBali / Indonesia
View all destination guides
Vaccines

Related Vaccines

Other vaccines available at our London clinic. Your pharmacist will confirm what you need for your trip.

DTP Booster (Diphtheria, Tetanus & Polio)Flu Vaccine (Seasonal Influenza)Hepatitis A VaccineHepatitis B Vaccine
View all vaccines
Enquiries

Dengue Fever Vaccine FAQ’s

Not currently. The Qdenga vaccine (TAK-003) is approved in the UK but has specific eligibility criteria. The earlier Dengvaxia vaccine is only approved for people with confirmed previous dengue. Our pharmacist will assess your suitability and advise on the best approach — including whether bite prevention alone is appropriate for your trip.

Ready to Book?

Same day appointments available. Call ahead to book. No consultation fees.

Book an AppointmentCall 0207 405 1039